|
|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$112,260
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
|
Validation of potential early diagnostic and prognostic markers for pancreatic ca
|
5R21CA115478-02
|
$110,694
|
$110,694
|
CHIAO, PAUL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-03
|
$1,052,474
|
$263,119
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$94,960
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$1,134
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$4,791
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$68,110
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
USC Center for Transdisciplinary Research on Energetics*
|
3U54CA116848-03S1
|
$60,505
|
$30,253
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Center for Transdisciplinary Research on Energetics*
|
5U54CA116848-03
|
$2,282,557
|
$1,141,279
|
GORAN, MICHAEL
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S1
|
$75,930
|
$12,149
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S2
|
$172,091
|
$27,535
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
3P30CA036727-23S3
|
$175,726
|
$28,116
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
UNMC Eppley Cancer Center Support Grant
|
5P30CA036727-23
|
$1,493,701
|
$238,992
|
COWAN, KENNETH
|
UNIVERSITY OF NEBRASKA MEDICAL CENTER
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S2
|
$59,280
|
$1,778
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
3P30CA046592-20S3
|
$114,000
|
$3,420
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center Support Grant
|
5P30CA046592-20
|
$5,929,129
|
$177,874
|
WICHA, MAX
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
University of Michigan Comprehensive Cancer Center CCOP*
|
3U10CA074648-06S1
|
$14,723
|
$442
|
Brenner, Dean
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S1
|
$68,952
|
$690
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S2
|
$2,553,879
|
$25,539
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
Univ.of Calif., Irvine Cancer Center Support Grant
|
3P30CA062203-13S3
|
$59,791
|
$598
|
MEYSKENS, FRANK
|
UNIVERSITY OF CALIFORNIA IRVINE
|
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S2
|
$3,773,055
|
$37,731
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
|
UCCRC -Cancer Center Support Grant
|
3P30CA014599-32S3
|
$78,561
|
$786
|
LE BEAU, MICHELLE
|
UNIVERSITY OF CHICAGO
|
|
|
Tumor-priming Microparticles for Pancreatic Cancer
|
5R44CA103133-04
|
$565,979
|
$282,990
|
LU, ZE
|
OPTIMUM THERAPEUTICS, LLC
|
|
|
Tumor Suppressor Function of Smad4 by Ubiquitin
|
5R01CA108454-04
|
$224,756
|
$112,378
|
FENG, XIN-HUA
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Tumor Radiosensitization by Prenyltransferase Inhibitors
|
5R01CA073820-09
|
$179,207
|
$179,207
|
BERNHARD, ERIC
|
UNIVERSITY OF OXFORD
|
|
|
Tumor maintenance and development in mouse models
|
5U01CA105492-04
|
$458,655
|
$155,943
|
VARMUS, HAROLD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
|
|
Tumor Hypoxia: Molecular Studies & Clinical Exploitation
|
2P01CA067166-11A1
|
$1,581,538
|
$790,769
|
GIACCIA, AMATO
|
STANFORD UNIVERSITY
|
|
|
Tumor Glycomics Laboratory for Discovery of Pancreatic Cancer Markers
|
1U01CA128454-01
|
$719,834
|
$719,834
|
PIERCE, JAMES
|
UNIVERSITY OF GEORGIA (UGA)
|
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S2
|
$4,309,306
|
$129,279
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
TRANSLATIONAL RESEARCH IN CANCER
|
3P30CA056036-08S3
|
$57,159
|
$1,715
|
Pestell, Richard
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Transforming growth factor beta signaling pathways
|
2R01CA055536-16
|
$308,158
|
$77,040
|
HOWE, PHILIP
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
|
|
Transcriptional control in the genesis of pancreatic intraepithelial neoplasia
|
1R21CA127822-01
|
$149,500
|
$149,500
|
Ayer, Donald
|
UNIVERSITY OF UTAH
|
|
|
Traget-Driven Identification of Diagnostic Patterns in Pancreatic Adenocarcinoma
|
1R03CA130104-01
|
$77,250
|
$77,250
|
SILLETTI, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
|
Tissue Microarray Design and Development for Novel Gene and Gene Product Screenin
|
Z01 SC 010364
|
$515,375
|
$51,538
|
Kleiner, David
|
CCR (NCI)
|
|
|
Thioredoxin Inhibitor, PX-12, in Phase II Clinical Trial
|
5R44CA075923-07
|
$995,448
|
$995,448
|
KIRKPATRICK, LYNN
|
PROLX PHARMACEUTICALS CORPORATION
|
|
|
Thioredoxin Inhibition of Apoptosis and Cancer Treatment
|
5R01CA077204-09
|
$269,170
|
$33,646
|
POWIS, GARTH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
|
Therapeutic Targeting of Hypoxic and Oxidative Stress
|
2P01CA017094-28A2
|
$1,249,645
|
$624,823
|
DORR, ROBERT
|
UNIVERSITY OF ARIZONA
|
|
|
The synergy between radiotherapy and molecularly targeted agents
|
Z01 SC 010373
|
$435,626
|
$43,563
|
Camphausen, Kevin
|
CCR (NCI)
|
|
|
THE ROLE OF TSNA IN PANCREATIC CANCER
|
5R01CA076228-08
|
$243,090
|
$243,090
|
PROKOPCZYK, BOGDAN
|
PENNSYLVANIA STATE UNIV HERSHEY MED CTR
|
|
|
The role of n-3 polyunsaturated fatty acids in pancreatic cancer
|
1R01CA122042-01A1
|
$292,600
|
$292,600
|
Eibl, Guido
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
The role of EGFR signaling in progression of Kras-induced pacreatic tumors
|
5R21CA123061-02
|
$191,523
|
$191,523
|
MEANS, ANNA
|
VANDERBILT UNIVERSITY
|
|
|
The Role of CXCR2 in Pancreatic Cancer
|
1R21CA124609-01A1
|
$154,000
|
$154,000
|
Hines, Oscar
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
The Role of COX-2 and PPAR-Gamma in Pancreatic Cancer
|
5R01CA104027-04
|
$270,281
|
$270,281
|
Eibl, Guido
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
|
The Robert H.Lurie Comprehensive Cancer Center
|
3P30CA060553-13S5
|
$90,600
|
$1,812
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
2P30CA060553-14
|
$5,033,724
|
$100,674
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S1
|
$216,819
|
$4,336
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The Robert H. Lurie Comprehensive Cancer Center
|
3P30CA060553-14S2
|
$66,034
|
$1,321
|
ROSEN, STEVEN
|
NORTHWESTERN UNIVERSITY
|
|
|
The RaLGTPase Regulatory Network
|
1R01CA129451-01
|
$238,640
|
$119,320
|
White, Michael
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
|
The Ohio State University Comprehensive Cancer Center-Supplement
|
3P30CA016058-32S1
|
$232,765
|
$6,983
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
|
The Ohio State University Comprehensive Cancer Center
|
3P30CA016058-32S2
|
$84,897
|
$2,547
|
CALIGIURI, MICHAEL
|
OHIO STATE UNIVERSITY
|
|
Total relevant funding to Pancreas for this search: $73,273,795
|
